Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.5B | 4.7B | 8.6B | 7.4B |
Cost of revenue | 3.5B | 1.1B | 2.2B | 1.8B |
Gross profit | 13.0B | 3.6B | 6.4B | 5.6B |
Operating expense | ||||
Research & development | 34.0M | 46.1M | 46.6M | 31.1M |
Selling general and admin | 1.8B | 291.2M | 2.2B | 282.7M |
Other operating expenses | 2.3B | 1.2B | 1.2B | 1.5B |
Operating income | 8.9B | 1.1B | 3.8B | 2.9B |
Non operating interest income | ||||
Income | 9.6M | 11.5M | 15.4M | 8.5M |
Expense | 4.2M | 12.9M | 5.6M | 5.6M |
Other income expense | — | — | — | — |
Pretax income | 8.9B | 1.3B | 3.9B | 2.9B |
Tax provision | 2.2B | 393.9M | 1.0B | 782.8M |
Net income | 6.7B | 891.9M | 2.9B | 2.2B |
Basic EPS | 5.5 | — | — | — |
Diluted EPS | 5.5 | — | — | — |
Basic average shares | 1.2B | — | — | — |
Diluted average shares | 1.2B | — | — | — |
EBITDA | 8.9B | 1.1B | 3.9B | 2.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | -8.0M | 967.6K | 3.2M | -10.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |